原发膀胱小细胞癌1例报告并文献分析

J4 ›› 2012, Vol. 11 ›› Issue (3): 52-54.

原发膀胱小细胞癌1例报告并文献分析

目的:报告原发膀胱小细胞癌1例并研究其诊治方法。方法:回顾性分析1例患者的临床和病理资料并结合文献复习讨论。结果:患者以无痛性全程血尿就诊，发现膀胱右侧壁肿块，病检为小细胞癌，免疫组化示神经内分泌标记物Syn、CoA、NSE阳性，行TURBt两月后复发，随即行膀胱全切回肠新膀胱原位排尿术，随访1年无复发和转移。结论:此病少见，恶性程度高，尽管其临床特征同移行细胞癌相同，但治疗方案并无统一意见，治疗需多种手段共同干预，包括手术和放、化疗。

昆明医学院第二附属医院泌肾外科，昆明 650101

收稿日期:2011-12-14 出版日期:2012-03-15 发布日期:2012-03-15
作者简介:李志鹏，主任医师，主要从事泌尿外科研究.

On Primary Small Cell Carcinoma of the Bladder

Department of Urology and Nephrosis, the Second Affiliated Hospital of Kunming Medical College, Kunming 650101, China

Received:2011-12-14 Online:2012-03-15 Published:2012-03-15

摘要/Abstract

摘要：

关键词: 膀胱, 小细胞, 癌

Abstract:

Objective: To report a case of primary small cell carcinoma（SCC）of the bladder and study the diagnosis and treatment.Methods：A retrospective study on clinical and pathological data of a patient with primary small cell carcinoma of the bladder, and a review of the literature on this topic were presented. Results: The outstanding symptom of the case was hematuria. A tumor was located in the right wall of the bladder. On histopathological study, the tumor was characterized by small cell carcinoma, immunohistochemical assay of Syn, EMA and NSE being positive in the tumor tissues. The case underwent TURBt with adjuvant chemotherapy, and there was a small tumor recurrence after 2 months. The case underwent total cystectomy and an ileal orthotopic neo-bladder procedure. After 1 year, there was no evidence for recurrence and metastases. Conclusion: SCC of the urinary bladder is rare, highly aggressive neoplasm, though the clinical and epidemiological characteristics have some similarities with transitional cell carcinoma. Its therapy advice is not yet uniform and its treatment should be multidisciplinary, including surgery, chemotherapy and radiotherapy.

Key words: bladder, small cell, carcinoma

中图分类号:

R737.14

. 原发膀胱小细胞癌1例报告并文献分析[J]. J4, 2012, 11(3): 52-54.

参考文献

〔1〕Trias I，Algaba F，Condom E，et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases〔J〕. Eur Urol，2001，39（1）:85-90.
〔2〕郭应禄，曾荔.临床泌尿外科病理学〔M〕.北京：北京大学医学出版社，2003:206-207.
〔3〕Liang Cheng，Chong-Xian Pan，Ximing J Yang，et al.Small cell carcinoma of the urinary bladder. A
clinicopathologic analysis of 64 patients〔J〕. Cancer，2004，101（5）:957-962.
〔4〕Mills SE，Wolfe JT，Weiss MA，et al. Small cell undifferentiated carcinoma of the urinary bladder. A
light-microscopic， immunocytochemical， and ultrastructural study of 12 cases〔J〕. Am J Surg Pathol，
1987（11）:606-617.
〔5〕Edward M C，Vos W，De Voogt H J，et al. Small cell carcinoma of the urinary bladder a c1inicopathologic，morphometric，immunohistochemica1 and ultrastructural study of 18 cases〔J〕.Cancer，1989，64:1347-1357.
〔6〕Jones TD， Kernek KM， Yang XJ，et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases〔J〕. Hum Pathol，2005，36（7）:718-723.
〔7〕Soriano P，Navarro S，Gil M，et al. Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases〔J〕. Virchows Arch，2004，445（3）:292-297.
〔8〕Iczkowski KA，Shanks JH，Bostwick DG，et al. Loss of CD44 variant 6 expression differentiates small cell
carcinoma of urinary bladder from urothelial（transitional cell）carcinoma〔J〕. Histopathology，1998，32（4）:322-327.
〔9〕Edward Karpman，Zelanna Goldberg，Amir Saffarlan，et al. Analysis of treatment for small cell cancer of the bladder and report of three cases〔J〕. Urology，2004，64（3）:494-498.
〔10〕Grignon DJ，Ro JY，Ayala AG，et al. Small cell carcinoma of the urinary bladder. A clinicopathologic
analysis of 22 cases〔J〕. Cancer，1992，69（2）:527-536.
〔11〕Chong-Xian Pan，Ximing J Yang，Antonio Lopez-Beltran，et al.c-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications[J]. Mod Path，2005（18）：320-323.

[1]	朱文娟, 桂玲玲, 明　静. 胃癌术后患者心理应激与赋权及应对方式关系研究[J]. 大理大学学报, 2026, 11(4): 28-34.
[2]	魏　壮, 胡阳阳. 食管癌根治术联合放化疗对中晚期食管癌患者临床疗效及#br# 免疫功能影响[J]. 大理大学学报, 2026, 11(2): 37-41.
[3]	齐晓鹏, 程　伟, 田　畅, 陶　伦, 罗晓红, 舒武英. LINC00460-miR143-COL1A1 表达调控在结直肠癌细胞增殖、#br# 迁移和侵袭的作用机制研究[J]. 大理大学学报, 2025, 10(8): 41-50.
[4]	张　露, 韩正全, 章海斌, 高振远. 瑞戈非尼联合PD-1抑制剂治疗对中晚期直肠癌患者生存率、#br# 疾病相关因子及不良反应的影响[J]. 大理大学学报, 2025, 10(8): 57-61.
[5]	李忠连, 杨琼艳, 罗瑞施, 章子霞, 李文银, 郭　颖. 大理地区女大学生对HPV和HPV疫苗的知晓度、接受度及其#br# 影响因素分析[J]. 大理大学学报, 2025, 10(8): 73-79.
[6]	杨文荣, 李爱民, 杨利杰, 宋　政, 李仲华, 杨万春, 茶剑媛. 乙酰基转移酶KAT2A和Survivin蛋白乙酰化在食管癌#br# 组织中的表达分析[J]. 大理大学学报, 2025, 10(2): 51-54.
[7]	洪　虓, 廖圣恺, 周　晶, 李建成. 血清HGF、uPA、IL-17、IL-24对口腔鳞状细胞癌患者预后的影响[J]. 大理大学学报, 2025, 10(2): 60-66.
[8]	王衔钰 , 毛建华 , 吴毕华 , 苏霜艳 , 和金龙 , 梁启浪 , 陈奕明, . PSCA表达对胰腺癌细胞迁移、增殖和侵袭的影响 [J]. 大理大学学报, 2025, 10(10): 22-31.
[9]	仇友政, 王　靖. 基于Web of Science非小细胞肺癌相关lncRNA研究的可视化分析#br#[J]. 大理大学学报, 2024, 9(4): 74-81.
[10]	魏　伟, 徐静雅, 冯慧俊, 张　霞, 武　静, 张　伟, 江　峰. T1期乳腺癌超声特征与ER、PR、HER-2、Ki-67表达的相关性分析[J]. 大理大学学报, 2024, 9(2): 55-62.
[11]	赵　森, 周　华. 地衣酸对胰腺癌细胞系PANC-1的抗增殖作用 [J]. 大理大学学报, 2024, 9(10): 26-31.
[12]	杨翠英 , 陈奕明. 基因DPT在胃癌患者中的表达情况分析 [J]. 大理大学学报, 2024, 9(10): 40-43.
[13]	吴茂芳, 石　汶, 肖寿勇, 蔡静静, 刘曾平, 方　红. ⅢA/N2期非小细胞肺癌患者术后放疗的倾向评分匹配分析 [J]. 大理大学学报, 2023, 8(8): 64-70.
[14]	闫其星, 赵李妮, 唐文军, 陈进芳, 方　草. 卵巢癌患者MMP-9基因多态性与TP方案近期疗效的相关性研究 [J]. 大理大学学报, 2023, 8(4): 50-53.
[15]	李威倩, 陈奕明, 张文婷, 苏莹珍, 帅红艳, Yu Xin. 基于生物信息学分析筛选胰腺癌差异表达基因 [J]. 大理大学学报, 2023, 8(2): 24-30.